We first verified that prostate cancer cells do not secrete this chemokine (Supplementary Fig. 7a) and that the inhibition of CCR3/CCL7 did not affect cell migration in response to 10% FCS (Supplementary Fig. 7b). Here, CCR3 is linked to prostate cancer.